Evidence map›Paper›PMID 41540004›Full record

ArticleNature communications2026

Mixed-model and transcriptome-wide association analyses identify transcription factors and genes associated with colorectal cancer susceptibility.

Zhishan Chen, Wenqiang Song, Qing Li, Chao Li, Wanqing Wen, Jeroen R Huyghe, Philip J Law, Ceres Fernandez-Rozadilla, Maria N Timofeeva, Minta Thomas and 48 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

58 authors.

Zhishan Chen *Division of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Wenqiang Song *Division of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Qing Li *Division of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.ORCID http://orcid.org/0009-0005-1327-4347
Chao LiDivision of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Wanqing WenDivision of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-3004-5168
Jeroen R HuyghePublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-6027-9806
Philip J LawDivision of Genetics and Epidemiology, Institute of Cancer Research, London, UK.ORCID http://orcid.org/0000-0001-9663-4611
Ceres Fernandez-RozadillaEdinburgh Cancer Research Centre, Institute of Genomics and Cancer, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0001-7330-4804
Maria N TimofeevaColon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Minta ThomasPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-9337-7015
Stephanie L SchmitGenomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-5931-1194
Vicente MartinConsortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.ORCID http://orcid.org/0000-0003-0552-2804
Matthew DevallCenter for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.ORCID http://orcid.org/0000-0001-5943-4397
Christopher DampierCenter for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
Ferran Moratalla-NavarroConsortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.ORCID http://orcid.org/0000-0001-7858-5713
Qiuyin CaiDivision of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-9384-5648
Jifeng WangDivision of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-0649-3494
Jiajun ShiDivision of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-5194-0009
Sun-Seog KweonDepartment of Preventive Medicine, Chonnam National University Medical School, Gwangju, South Korea.
Chizu TanikawaLaboratory of Genome Technology, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Wei-Hua JiaState Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China.ORCID http://orcid.org/0000-0002-0528-8715
Xiang ShuDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-4129-9403
Jirong LongDivision of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-7433-9766
Jing GaoClinical Research Institute, Shanghai Jiao Tong University School of Medicine, 227, South Chongqing Road, Shanghai, China.
Jeongseon KimDepartment of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Gyeonggi-do, Seoul, South Korea.ORCID http://orcid.org/0000-0002-0889-2686
Aesun ShinDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul, Korea.ORCID http://orcid.org/0000-0002-6426-1969
Keitaro MatsuoDivision of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID http://orcid.org/0000-0003-1761-6314
Sun Ha JeeDepartment of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, South Korea.ORCID http://orcid.org/0000-0001-9519-3068
Keum Ji JungDepartment of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, South Korea.ORCID http://orcid.org/0000-0003-4993-0666
Nan WangDepartment of General Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Dong-Hyun KimDepartment of Social and Preventive Medicine, Hallym University College of Medicine, Okcheon-dong, South Korea.
Jie PingDivision of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-9907-5819
Gong YangDivision of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Min-Ho ShinDepartment of Preventive Medicine, Chonnam National University Medical School, Gwangju, South Korea.ORCID http://orcid.org/0000-0002-2217-5624
Zefang RenSchool of Public Health, Sun Yat-sen University, Guangzhou, China.ORCID http://orcid.org/0000-0002-7785-4704
Jae Hwan OhCenter for Colorectal Cancer, National Cancer Center Hospital, National Cancer Center, Gyeonggi-do, Seoul, South Korea.
Isao OzeDivision of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID http://orcid.org/0000-0002-0762-1147
Yoon-Ok AhnDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul, Korea.
Yu-Tang GaoState Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhi-Zhong PanState Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China.
Yoichiro KamataniLaboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Kanagawa, Yokohama, Japan.ORCID http://orcid.org/0000-0001-8748-5597
Luc Van KaerDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-5275-2309
Lan WuDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Bingshan LiDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-2129-168X
Koichi MatsudaLaboratory of Clinical Genome Sequencing, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7292-2686
Xiao-Ou ShuDivision of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Li HsuPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-8168-4712
Malcolm G DunlopColon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-3033-5851
Stephen B GruberDepartment of Medical Oncology and Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA.ORCID http://orcid.org/0000-0001-8656-7822
Richard HoulstonSection of Cancer Genetics, Institute of Cancer Research, Sutton, UK.ORCID http://orcid.org/0000-0002-5268-0242
Ian TomlinsonEdinburgh Cancer Research Centre, Institute of Genomics and Cancer, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-3037-1470
Li LiCenter for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
Ken S LauEpithelial Biology Center and Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Victor MorenoConsortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.ORCID http://orcid.org/0000-0002-2818-5487
Graham CaseyCenter for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
Ulrike PetersPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-5666-9318
Wei ZhengDivision of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Xingyi GuoDivision of Epidemiology, Department of Medicine,sss Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. xingyi.guo@vumc.org.ORCID http://orcid.org/0000-0001-5269-1294

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Leveraging Omics and Electronic Health Records Data to study Colorectal Adenoma genetics and Drug RepurposingR01CA297582 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GUO, XINGYI, YIN, ZHIJUN · 2025 to 2025
$4.2M
Transcriptome-wide association study to identify susceptibility genes for colorectal cancerR37CA227130 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GUO, XINGYI · 2018 to 2023
$3.7M
Uncovering colorectal cancer etiology and biology by integrating proteomics with other omics dataR01CA269589 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Xingyi Guo, Wei Zheng · 2023 to 2026
$2.9M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA269589NCI NIH HHS R01 CA297582NCI NIH HHS R37 CA227130
6 · The paper itself

Abstract

Susceptibility transcription factors (TF) whose DNA bindings are altered by genetic variants regulating colorectal cancer (CRC) risk genes remain poorly defined. Using generalized linear mixed models, we analyze 218 TF ChIP-Seq datasets alongside GWAS data from 100,204 CRC cases and 154,587 controls of East Asian and European ancestries. We identify 51 TFs and TF-cofactor interactions, including VDR-cofactors, as key regulators of CRC risk. Integrating these TF insights with transcriptome-wide association studies (TWAS), we further evaluate associations between genetically predicted gene expression, alternative splicing, and alternative polyadenylation with CRC risk, using RNA-seq data from 364 Asian-ancestry and 707 European-ancestry individuals. Multi-ancestry TWAS identify 222 risk genes, including 95 novel genes and 48 potentially druggable targets. Single-cell analysis provides additional functional evidence supporting ~45% of these genes, and experimental validation confirms oncogenic roles for RHPN2, IRS2, and TXN. Our findings elucidate key TF-gene regulatory networks and uncover novel CRC risk genes.

Indexed as

Colorectal NeoplasmsGenetic Predisposition to DiseaseTranscription FactorsTranscriptomeAlternative SplicingGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksGenome-Wide Association StudyHumansInsulin Receptor Substrate ProteinsPolymorphism, Single NucleotideInsulin Receptor Substrate ProteinsTranscription Factors

Identifiers

PMID41540004
PMCPMC12877115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.